• Open Access

Scientific Opinion on the substantiation of a health claim related to thiamin and maintenance of normal neurological development and function pursuant to Article 14 of Regulation (EC) No 1924/2006

Authors

  • EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)


  • Panel members: Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser-Berthold, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, Hendrik van Loveren and Hans Verhagen.
  • Correspondence: nda@efsa.europa.eu
  • Acknowledgement: The Panel wishes to thank the members of the Working Group on Claims for the preparatory work on this scientific opinion: Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Marina Heinonen, Hannu Korhonen, Martinus Løvik, Ambroise Martin, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Inge Tetens, Hendrik van Loveren and Hans Verhagen.
  • Adoption date: 28 January 2011
  • Published date: 10 February 2011
  • Question number: EFSA-Q-2009-00455
  • On request from: the Competent Authority of Germany following an application by HiPP GmbH

Abstract

Following an application from HiPP GmbH submitted pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of Germany, the Panel on Dietetic Products, Nutrition and Allergies was asked to deliver an opinion on the scientific substantiation of a health claim related to thiamin and maintenance of normal neurological development and function. Thiamin is a well recognised nutrient and is measurable in foods by established methods. Thiamin is considered to be sufficiently characterised. Maintenance of normal neurological development and function is considered to be a beneficial physiological effect. It is well recognised that the clinical signs of thiamin deficiency include mental changes, such as apathy, decrease in short-term memory, confusion and irritability as well as polyneuritis and paralysis of the peripheral nerves. All essential nutrients, including vitamins and minerals, are required for normal development of infants and children. The Panel concludes that a cause and effect relationship has been established between the dietary intake of thiamin and maintenance of normal neurological development and function. The following wording reflects the scientific evidence: “Thiamin contributes to the maintenance of normal neurological development and function.” The target population is infants and children up to 3 years.

Ancillary